How would you treat a BTKi naive p53 mutated MCL in 1st relapse with disease noted both systemically and in the CNS?

Community PollStarted

What is your preferred treatment for a BTKi-naive relapsed p53 mutated MCL with both systemic and CNS disease?

41 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer

Mednet Member

Hematology · University of California Irvine

Answered on

This is a case where I would likely still use ibrutinib. We know from years of experience that it gets into the CNS, and it's an incredibly effective drug in MCL. Zanu and acala should get into the CNS, but the companies have limited PK data for CNS penetration. The harder question (I think) is whet...

Join for free or sign in to see the full answer